Also known as آسٹیوپوروسس مینجمنٹ
Internal Medicine Specialist
MBBS, FCPS
Internal Medicine Specialist
MBBS, FCPS (Medicine)
Internal Medicine Specialist
M.B.B.S, F.C.P.S. (Medicine)
Internal Medicine Specialist
M.B.B.S, F.C.P.S. (Medicine)
Nephrologist
FRCP (Edinburgh,UK), FRCP (Ireland), MRCPS (Glasgow,UK), MRCP (Ireland), FCPS (Nephrology), FCPS (Medicine), Diplomate and Affiliate American Board of Regenerative Medicine (DABRM) , MBBS (KMU), FRCP ( Glasgow, UK)
Nephrologist
FRCP (Edinburgh,UK), FRCP (Ireland), MRCPS (Glasgow,UK), MRCP (Ireland), FCPS (Nephrology), FCPS (Medicine), Diplomate and Affiliate American Board of Regenerative Medicine (DABRM) , MBBS (KMU), FRCP ( Glasgow, UK)
Internal Medicine Specialist
MBBS (GOLD MEDALIST), MRCP (London, UK), Diploma Internal Medicine, Diploma Geriatric Medicine, MRCGP (London, UK)
Internal Medicine Specialist
MBBS (GOLD MEDALIST), MRCP (London, UK), Diploma Internal Medicine, Diploma Geriatric Medicine, MRCGP (London, UK)
Internal Medicine Specialist
MBBS, FCPS
Oncologist
MBBS , FCPS (Medicine) , FCPS (Medical Oncology)
Internal Medicine Specialist
M.B.B.S., F.C.P.S.
Rheumatologist
MBBS, FCPS (MEDICINE), FCPS (RHEUMATOLOGY)
Internal Medicine Specialist
MBBS, MD Internal Medicine
Bisphosphonates are used as first-line pharmacologictreatment for osteoporosis. In patients who cannot tolerate or whose symptoms do not improve with bisphosphonate therapy, teriparatide (Forteo) and denosumab (Prolia) are effective alternative medications to prevent osteoporotic fractures